<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Modesto-Lowe, Vania</style></author><author><style face="normal" font="default" size="100%">Swiezbin, Katie</style></author><author><style face="normal" font="default" size="100%">Chaplin, Margaret</style></author><author><style face="normal" font="default" size="100%">Hoefer, Gabriela</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Use and misuse of opioid agonists in opioid addiction</style></title><secondary-title><style face="normal" font="default" size="100%">Cleveland Clinic Journal of Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2017-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">377-384</style></pages><doi><style  face="normal" font="default" size="100%">10.3949/ccjm.84a.16091</style></doi><volume><style face="normal" font="default" size="100%">84</style></volume><issue><style face="normal" font="default" size="100%">5</style></issue><abstract><style  face="normal" font="default" size="100%">Although methadone (an opioid agonist) and buprenorphine (a partial opioid agonist) have evidence to support their use in treating opioid use disorder, they remain misunderstood and underutilized. In this article, we outline the risks and benefits of using these drugs as maintenance therapy in opioid-dependent patients.</style></abstract></record></records></xml>